EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Limited, each of which is a separate legal entity. Ernst & Young Limited is a Swiss company with registered seats in Switzerland providing services to clients in Switzerland.
Select your location
Local sites
Life Sciences
Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.
Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.
We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.
How EY can help
-
The EY Promotional Content Management Services team can provide you with support that will transform your processes and improve your results. Learn more.
Read more -
The EY Smart Reviewer can help your business accelerate and optimize the review and approval process for marketing and promotional materials. Find out how.
Read more -
Our Biopharma Launch Edge team can help your business achieve successful launches. Find out how.
Read more -
The EY Health Outcomes Platform aligns all stakeholders by providing a practical solution to operate value-based contracts at scale. Find out how.
Read more
Our latest thinking
The Basel Area Life Sciences Ecosystem in a Global Landscape
What do life science companies need to thrive and how does the Basel Area life sciences ecosystem compare internationally? Read our study to find out.
21 Jan 2025
Dr. Susanne Weissbäcker
Collaborative Care: The Role of Patient Data in Advancing AI in Healthcare
How to unlock AI’s potential in healthcare with patient-owned data
29 Oct 2024
Martin Blanke
The Unstoppables: Success stories of the world’s most inspiring entrepreneurs
The latest EY entrepreneurship documentary, “The Unstoppables 3,” features inspiring professional and personal entrepreneur success stories. Read more.
09 Apr 2024
Stasia Mitchell
What can we learn from the continuous glucose monitoring device market?
The continuous glucose monitoring (CGM) device market offers important lessons to diabetes medical device manufacturers on how to capture untapped market potential.
07 Mar 2024
Dr. Silvano Perrotta
Shaping the future of life sciences: AI‘s regulatory, risk and technology dimensions
EY’s whitepaper helps organizations navigate the complexities of AI to optimize performance and remain compliant.
19 Dec 2023
Alexei Koifman
Supply chain visibility strategic priority for pharma
With digitally driven end-to-end supply chain visibility, pharma companies will be better prepared for the next major supply chain disruption. Learn more.
04 Oct 2023
Derron Stark
If compensation is key, how do you unlock insights into market rates?
Salary reviews beyond simple benchmarks offer valuable insights into the remuneration practice of the market – and your own company.
23 Jun 2023
Radmilla Del Pozzo
Life Science Real Estate: The real estate asset class of the future
Resilient portfolio diversification through life science real estate – but what is behind this asset class?
14 Mar 2023
Erik Ganz
Nicolas Durand is the founder and CEO of Abionic SA, the company that developed the fastest in vitrodiagnostic platform in the world, the abioSCOPE.
25 Jun 2021
Frédéric Tissot
Johannes Galatsanos is Head of Data for Digital Core Transformation at Novartis, supporting the company to be at the forefront of Data & Digital in the pharmaceutical industry.
23 Jun 2021
EY Switzerland
Direct to your inbox
Stay up to date with our latest insights.